Literature DB >> 28676911

Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015.

Ji-Won Kim1, Sang Gyu Kwak2, Hwajeong Lee1, Seong-Kyu Kim1, Jung-Yoon Choe1, Sung-Hoon Park3.   

Abstract

The purpose of the present study was to investigate the prevalence and incidence of gout in Korea and predict the future prevalence and incidence of gout. Data were collected from the national health claims database. Patients who had at least one claim for gout between 2007 and 2015 were included in the study. The prevalence of gout from 2007 to 2015 and the incidence of gout from 2009 to 2015 were determined. We estimated sex- and age-specific prevalence and incidence of gout during the period. The prevalence and incidence of gout were predicted using time series analysis. The prevalence of gout (95% CI) increased from 3.49 (3.48-3.51) per 1000 persons in 2007 to 7.58 (7.55-7.60) per 1000 persons in 2015. The incidence of gout (95% CI) was 1.52 (1.51-1.53) in 2009 and rose to 1.94 (1.93-1.95) per 1000 persons in 2015. The prevalence and incidence of gout were higher in men than in women. The older population had a higher prevalence and incidence than the younger population. The increase in prevalence was higher in the older population than the younger population, whereas the increase in incidence was higher in the younger population than the older population. The predicted prevalence and incidence of gout (95% CI) in 2025 were 16.59 (15.85-17.34) per 1000 persons and 3.81 (3.14-4.47) per 1000 persons. The prevalence and incidence of gout increased in Korea between 2007 and 2015. Men and the older population had a higher prevalence and incidence of gout compared to women and the younger population. However, the incidence of gout in the younger population has increased rapidly in recent years.

Entities:  

Keywords:  Gout; Incidence; Korea; Prevalence

Mesh:

Year:  2017        PMID: 28676911     DOI: 10.1007/s00296-017-3768-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  33 in total

1.  The epidemiology of hyperuricaemia and gout in Taiwan aborigines.

Authors:  C T Chou; J S Lai
Journal:  Br J Rheumatol       Date:  1998-03

2.  Prevalence of gout with comorbidity aggregations in southern Taiwan.

Authors:  Fang-Yi Tu; Gau-Tyan Lin; Su-Shin Lee; Yi-Ching Tung; Hung-Ping Tu; Hung-Che Chiang
Journal:  Joint Bone Spine       Date:  2014-09-17       Impact factor: 4.929

3.  Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study.

Authors:  Janet W Maynard; Mara A McAdams-DeMarco; Andrew Law; Linda Kao; Allan C Gelber; Josef Coresh; Alan N Baer
Journal:  Am J Epidemiol       Date:  2013-12-13       Impact factor: 4.897

4.  Prevalence of comorbid conditions and prescription medication use among patients with gout and hyperuricemia in a managed care setting.

Authors:  Aylin Altan Riedel; Mike Nelson; Katrine Wallace; Nancy Joseph-Ridge; Michele Cleary; Adel G Fam
Journal:  J Clin Rheumatol       Date:  2004-12       Impact factor: 3.517

5.  Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study.

Authors:  Hein J E M Janssens; Paul G J Arts; Bianca W M Schalk; Marion C J Biermans
Journal:  Joint Bone Spine       Date:  2016-05-25       Impact factor: 4.929

6.  Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort.

Authors:  Vidula Bhole; Mary de Vera; M Mushfiqur Rahman; Eswar Krishnan; Hyon Choi
Journal:  Arthritis Rheum       Date:  2010-04

7.  Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

8.  Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China.

Authors:  Zhimin Miao; Changgui Li; Ying Chen; Shihua Zhao; Yangang Wang; Zhongchao Wang; Xinyan Chen; Feng Xu; Fang Wang; Ruixia Sun; Jianxia Hu; Wei Song; Shengli Yan; Cong-Yi Wang
Journal:  J Rheumatol       Date:  2008-07-15       Impact factor: 4.666

9.  Incidence and risk factors for gout in white men.

Authors:  R Roubenoff; M J Klag; L A Mead; K Y Liang; A J Seidler; M C Hochberg
Journal:  JAMA       Date:  1991-12-04       Impact factor: 56.272

10.  Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.

Authors:  Hyon K Choi; Gary Curhan
Journal:  BMJ       Date:  2008-01-31
View more
  27 in total

1.  Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample.

Authors:  Yunkyung Kim; Jihun Kang; Geun-Tae Kim
Journal:  Clin Rheumatol       Date:  2018-05-23       Impact factor: 2.980

2.  The Daniel K. Inouye College of Pharmacy Scripts: Perspectives on the Epidemiology of Gout and Hyperuricemia.

Authors:  Youssef M Roman
Journal:  Hawaii J Med Public Health       Date:  2019-02

3.  Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016.

Authors:  Michael Chen-Xu; Chio Yokose; Sharan K Rai; Michael H Pillinger; Hyon K Choi
Journal:  Arthritis Rheumatol       Date:  2019-04-15       Impact factor: 10.995

4.  The Occurrence of Nephrolithiasis in Gout Patients: A Longitudinal Follow-Up Study Using a National Health Screening Cohort.

Authors:  So Young Kim; Dae Myoung Yoo; Ji Hee Kim; Mi Jung Kwon; Joo-Hee Kim; Jung Woo Lee; Woo Jin Bang; Hyo Geun Choi
Journal:  Life (Basel)       Date:  2022-04-28

5.  Cause-Specific Mortality in Patients with Gout in the United States Veteran's Health Administration: A Matched Cohort Study.

Authors:  Lindsay N Helget; Bryant R England; Punyasha Roul; Harlan Sayles; Alison D Petro; Tuhina Neogi; James R O'Dell; Ted R Mikuls
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-03-16       Impact factor: 5.178

Review 6.  Uric acid extrarenal excretion: the gut microbiome as an evident yet understated factor in gout development.

Authors:  Eder Orlando Méndez-Salazar; Gabriela Angélica Martínez-Nava
Journal:  Rheumatol Int       Date:  2021-09-29       Impact factor: 2.631

7.  Associations of Serum Retinol and α-Tocopherol Levels with Uric Acid Concentrations: Analysis of a Population-Based, Nationally Representative Sample.

Authors:  Yunkyung Kim; Jung Hee Choi; Jihun Kang; Geun-Tae Kim; Seung-Geun Lee
Journal:  Nutrients       Date:  2020-06-17       Impact factor: 5.717

8.  Elderly Patients Exhibit Stronger Inflammatory Responses during Gout Attacks.

Authors:  Jae Hyun Lee; Ji Ae Yang; Kichul Shin; Ga Hye Lee; Won Woo Lee; Eun Young Lee; Yeong Wook Song; Eun Bong Lee; Jin Kyun Park
Journal:  J Korean Med Sci       Date:  2017-12       Impact factor: 2.153

Review 9.  Juvenile-onset gout and adipsic diabetes insipidus: A case report and literature review.

Authors:  Yun Zhang; Dongmei Wang; Yiding Feng; Wen Zhang; Xuejun Zeng
Journal:  J Int Med Res       Date:  2018-10-01       Impact factor: 1.671

10.  Effect of Uric Acid on the Development of Chronic Kidney Disease: The Korean Multi-Rural Communities Cohort Study.

Authors:  Kwang Ho Mun; Gyeong Im Yu; Bo Youl Choi; Mi Kyung Kim; Min-Ho Shin; Dong Hoon Shin
Journal:  J Prev Med Public Health       Date:  2018-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.